SCHEMBL9850372

SCHEMBL9850372

COc1ccc(S(=O)(=O)OCC2CCCN2C(=O)OC(C)(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
STS P08842 1/20 0.51
MMP1 P03956 5/20 0.46
MMP9 P14780 5/20 0.46
MMP13 P45452 4/20 0.46
MMP3 P08254 4/20 0.45
MMP7 P09237 4/20 0.45
MMP8 P22894 3/20 0.45
MMP2 P08253 2/20 0.45
ALDH1A1 P00352 1/20 0.45
MEN1 O00255 2/20 0.45
KMT2A Q03164 2/20 0.45
APP P05067 1/20 0.44
HTR1A P08908 1/20 0.44
ADRA2A P08913 1/20 0.44
DRD2 P14416 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
SLC6A2 P23975 1/20 0.44
HRH2 P25021 1/20 0.44
HTR1D P28221 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9850364 1.00 STS (0.51) STSMMP1MMP9MMP13MMP3
SCHEMBL345625 0.89 LMNA (0.47) MMP13ALDH1A1MEN1KMT2AAPP
SCHEMBL143674 0.89 LMNA (0.47) MMP13ALDH1A1MEN1KMT2AAPP
SCHEMBL86666 0.89 LMNA (0.47) MMP13ALDH1A1MEN1KMT2AAPP
SCHEMBL7918528 0.87 HCRTR2 (0.49) STSMEN1KMT2AAPPHTR1A
SCHEMBL7918530 0.87 HCRTR2 (0.49) STSMEN1KMT2AAPPHTR1A
SCHEMBL6535308 0.86 GPR119 (0.49) ALDH1A1MEN1KMT2AHRH2GPR119
SCHEMBL6535548 0.86 GPR119 (0.49) ALDH1A1MEN1KMT2AHRH2GPR119
SCHEMBL4809535 0.85 LMNA (0.43) MMP13ALDH1A1MEN1KMT2AAPP
SCHEMBL345693 0.81 GPR119 (0.44) STSMMP13MEN1KMT2AGPR119

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0430544-A1 Process for resolving chiral intermediates used in making calcium channel blockers E.R. SQUIBB & SONS, INC. (US) 1991-06-05 EP disclosed
US-4963671-A Process for resolving chiral intermediates used in making calcium channel blockers E. R. SQUIBB & SONS, INC. (US) 1990-10-16 US disclosed